Blog

A new Hong Kong study has found that recipients of the BioNT

A new Hong Kong study has found that recipients of the BioNT -219093433_526426795344153_3282549575207171714_n.jpg?stp=dst-jpg_e35&_nc_ht=scontent-sjc3-1.cdninstagram

A new Hong Kong study has found that recipients of the BioNTech Covid-19 vaccine have 10 times more antibodies than those who took Sinovac, with the latter generating levels of the virus-targeting proteins that were “similar or lower” than the naturally occurring ones seen in recovered patients.⁠

The findings by the University of Hong Kong, published in Lancet Microbe on Friday, could suggest the need for “alternative strategies” – including booster shots – to increase Sinovac recipients’ antibody concentrations and protection against Covid-19, according to the researchers.⁠

The presence of antibodies is a sign of a previous infection, or that a vaccine is working to protect an individual, but the quantity of the proteins generated by the body to identify and neutralise the coronavirus does not directly correlate to the level of immunity.⁠

However, there is increasing evidence that higher levels generally correspond with stronger and longer-lasting protection against infection, according to experts.⁠

More info at link in bio.⁠
.⁠
.⁠
.⁠
.⁠
.⁠

Charity In China report

Paypal account: fund@charityinchina.cn

Follow facebook page:Charity In China

Support Alipay/支付宝 To Donate

Scan Alipay QR Code


Support Paypal To Donate
PAYPAL DONATION

Thank you!
And we also accept the donation of Bitcoin.

Our Bitcoin address : 16ih3dGgfNf3TtrwgKzMnYbtixrQqEFk14

Scan QR Code

Thank you for your love